← Back to list

WisdomTree BioRevolution UCITS ETF USD Acc

WisdomTree BioRevolution ESG Screened

Equities Sustainable (ESG)

ISIN
IE000O8KMPM1
Issuer
WisdomTree
TER
0.45%
Latest closing price
21.52 EUR · Source: Yahoo
Fund Size
€35 m As of: Sep 30, 2026
Domicile
Ireland
Distribution Policy
Accumulating
Replication Method
Physical
Base Currency
USD
WKN / Ticker
A3CY21 / WRNA

Closing price of the trading day shown, not a real-time price. Prices can differ by exchange and trading currency.

Data availability

Data is available for 5 of 5 areas for this fund.

  • Master data (TER, index, size): As of: Sep 30, 2026
  • Closing price: As of: Nov 20, 2026
  • Price history (at least 20 prices): As of: Nov 20, 2026
  • Holdings: As of: Jul 29, 2026
  • Risk figures: As of: Nov 22, 2026

Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.

At a glance

Data as of

WisdomTree BioRevolution UCITS ETF USD Acc (ISIN IE000O8KMPM1) is a fund from WisdomTree (fund type: ETF). Benchmark index: WisdomTree BioRevolution ESG Screened. Its ongoing charges (TER) are 0.45% per year. The fund size is €35 m. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Ireland. Latest closing price: 21.52 EUR (as of Nov 20, 2026).

Key Facts
  • Launch date 03.12.2021 (4 years)
  • Number of Holdings 79
  • Strategy Passive (index tracking)
  • Base Currency USD
  • Currency hedging No
  • Distribution Policy Accumulating
  • Replication Method Physical
  • Securities lending No
  • Domicile IE
  • UCITS Compliant Yes

Price development

Loading …

Error loading comparison.
There is not enough price data available for this period yet.

Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.

Risk figures

Volatility
33.92 %
Annualised range of fluctuation of daily price changes.
Max Drawdown
−14.04 %
Largest price decline from a peak to the following low within the period.
Sharpe Ratio
-1.50
Return above the risk-free rate relative to volatility. Of limited significance over at most 12 months.

Own calculation from 34 daily closing prices from Oct 6, 2026 to Nov 20, 2026 (at most 12 months), calculated on Nov 22, 2026. Sharpe ratio uses an assumed risk-free rate of 2 % p.a.

The price history covers less than 12 months. The figures are therefore of limited significance and not comparable with annual figures from other sources.

The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.

Documents

We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.

Tracking difference and tracking error

We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.

What does the fund invest in?
As of 29.07.2026 · Source: justETF / etfdb
Sector Breakdown
  • Health care 87.0%
  • Basic materials 7.3%
  • Consumer staples 4.2%
  • Other 1.5%
Country Breakdown
  • United States 83.9%
  • Germany 3.2%
  • Switzerland 3.0%
  • Other 2.8%
  • United Kingdom 2.7%
  • Netherlands 2.4%
  • Denmark 2.0%

Holdings

Showing 10 holdings that together make up 30.7 % of fund assets. (out of 79 holdings in total).

Top Holdings
# Name ISIN Weight
1 Twist Bioscience US90184D1000 5.27 %
2 Eli Lilly & Co. US5324571083 4.40 %
3 Moderna US60770K1079 3.45 %
4 Johnson & Johnson US4781601046 3.29 %
5 Immunome US45257U1088 2.63 %
6 United Therapeutics Corp US91307C1027 2.54 %
7 10x Genomics US88025U1097 2.33 %
8 Natera US6323071042 2.32 %
9 Corteva US22052L1044 2.26 %
10 Darling Ingredients US2372661015 2.22 %
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?
Cost in year 1
–
Total cost impact
–

Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.

Alternatives on the same index
Other ETFs tracking the WisdomTree BioRevolution ESG Screened – cheapest first.
We know of no other ETFs tracking exactly this index.

Frequently asked questions about the WisdomTree BioRevolution UCITS ETF USD Acc

The total expense ratio (TER) of the WisdomTree BioRevolution UCITS ETF USD Acc is 0.45% per year. The costs are deducted from the fund assets on an ongoing basis and are already reflected in its performance.

The WisdomTree BioRevolution UCITS ETF USD Acc tracks the WisdomTree BioRevolution ESG Screened. Our index encyclopedia explains the index and lists all funds that track it.

The WisdomTree BioRevolution UCITS ETF USD Acc is accumulating: income such as dividends is not paid out but automatically reinvested in the fund.

The WisdomTree BioRevolution UCITS ETF USD Acc uses physical replication: it holds the securities of the index directly – either in full or as a representative sample (sampling).

The fund size of the WisdomTree BioRevolution UCITS ETF USD Acc is €35 m. A large fund size usually indicates good tradability and a lower risk of the fund being closed.

The WisdomTree BioRevolution UCITS ETF USD Acc is domiciled in Ireland. The fund domicile affects, among other things, how withholding taxes are treated inside the fund.

The provider (issuer) of the WisdomTree BioRevolution UCITS ETF USD Acc is WisdomTree.

All information without guarantee. It is provided for information purposes only and does not constitute investment advice.